EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Artificial Intelligence for Discovery in Life Sciences

Sushovan Chanda, Silvio O Rizzoli iD, Ali H Shaib iD

Bioconjugate Chemistry · 2026

DOI: 10.1021/acs.bioconjchem.6c00230 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioconjugate Chemistry, 2026. Verfasst von Sushovan Chanda und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuro- and Sensory Physiology, University Medical Center Göttingen, Göttingen 37073, Germany. Hauptthemen laut MEDLINE: Artificial Intelligence, Biological Science Disciplines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), Chan Zuckerberg Initiative (CZI), European Union?s Horizon 2020 research and innovation programme, European Research Council (ERC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial intelligence is becoming a transformative tool in life sciences, not just by improving the results of existing technologies but also by introducing fundamental new ways of discovery. Initially applied to denoising, segmentation, or pattern recognition, it now extends across microscopy, structural biology, protein engineering, experimental design, and hypothesis generation. In imaging, deep learning enhances fluorescence, cryo-EM, and expansion microscopy and increasingly links optical and non-optical modalities. Beyond imaging, AI accelerates fluorescent probe development, while large language models and multi-agent systems are beginning to synthesize literature, generate hypotheses, and guide experiments. We survey these developments across imaging and non-imaging domains, from microscopy and structural biology to molecular design, hypothesis generation, and autonomous experimentation. We discuss the convergence of AI with tools from chemistry to instrumentation and explain challenges in validation, interpretability, generalizability, and autonomy. We conclude that AI is beginning to connect measurement, design, and reasoning to accelerate biological discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceBiological Science DisciplinesHumansLarge Language ModelsAnimals

Autor:innen und Institutionen

  • Department of Neuro- and Sensory Physiology, University Medical Center Göttingen, Göttingen 37073, Germany.
  • Center for Biostructural Imaging of Neurodegeneration, University Medical Center Göttingen, Göttingen 37073, Germany.

ORCID-Profile: Silvio O Rizzoli, Ali H Shaib

Förderung

  • German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)
  • Chan Zuckerberg Initiative (CZI)
  • European Union?s Horizon 2020 research and innovation programme, European Research Council (ERC)

Zitieren

APA

Chanda, S., Rizzoli, S. O., & Shaib, A. H. (2026). Artificial Intelligence for Discovery in Life Sciences. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.6c00230

Vancouver

Chanda S, Rizzoli SO, Shaib AH. Artificial Intelligence for Discovery in Life Sciences. Bioconjugate Chemistry. 2026. doi:10.1021/acs.bioconjchem.6c00230

BibTeX
@article{Chanda2026,
  author = {Chanda, Sushovan and Rizzoli, Silvio O and Shaib, Ali H},
  title = {Artificial Intelligence for Discovery in Life Sciences},
  journal = {Bioconjugate Chemistry},
  year = {2026},
  doi = {10.1021/acs.bioconjchem.6c00230}
}
Kostenlos starten →